• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肾源性系统性纤维化和钆沉积的时代中的非对比磁共振血管造影。

Noncontrast Magnetic Resonance Angiography in the Era of Nephrogenic Systemic Fibrosis and Gadolinium Deposition.

机构信息

Department of Radiology, Columbia University Medical Center, New York, NY.

出版信息

J Comput Assist Tomogr. 2021;45(1):37-51. doi: 10.1097/RCT.0000000000001074.

DOI:10.1097/RCT.0000000000001074
PMID:32976265
Abstract

Gadolinium-based contrast agents for clinical magnetic resonance imaging are overall safe. However, the discovery of nephrogenic systemic fibrosis in patients with severe renal impairment and gadolinium deposition in patients receiving contrast have generated developments in contrast-free imaging of the vasculature, that is, noncontrast magnetic resonance angiography. This article presents an update on noncontrast magnetic resonance angiography techniques, with comparison to other imaging alternatives. Potential benefits and challenges to implementation, and evidence to date for various clinical applications are discussed.

摘要

用于临床磁共振成像的钆基造影剂总体上是安全的。然而,在严重肾功能损害的患者中发现了肾源性系统性纤维化,以及在接受造影的患者中发现了钆沉积,这促使人们开发了血管的无造影成像技术,即磁共振血管造影。本文介绍了非对比磁共振血管造影技术的最新进展,并与其他成像方法进行了比较。讨论了实施的潜在益处和挑战,以及目前各种临床应用的证据。

相似文献

1
Noncontrast Magnetic Resonance Angiography in the Era of Nephrogenic Systemic Fibrosis and Gadolinium Deposition.在肾源性系统性纤维化和钆沉积的时代中的非对比磁共振血管造影。
J Comput Assist Tomogr. 2021;45(1):37-51. doi: 10.1097/RCT.0000000000001074.
2
Contemporary applications and limitations of magnetic resonance imaging contrast materials.当代磁共振成像对比剂的应用及局限性。
J Urol. 2010 Jan;183(1):27-33. doi: 10.1016/j.juro.2009.09.029.
3
Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.与钆基造影剂相关的肾源性系统性纤维化的相关研究进展。
Int J Urol. 2012 Sep;19(9):806-11. doi: 10.1111/j.1442-2042.2012.03042.x. Epub 2012 May 9.
4
Nephrogenic systemic fibrosis developed after recovery from acute renal failure: gadolinium as a possible aetiological factor.急性肾衰竭恢复后发生肾源性系统性纤维化:钆作为可能的病因因素。
J Eur Acad Dermatol Venereol. 2009 Mar;23(3):339-40. doi: 10.1111/j.1468-3083.2008.02877.x. Epub 2008 Jun 19.
5
Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.肾源性纤维化皮肤病/肾源性系统性纤维化
Eur J Dermatol. 2009 Jan-Feb;19(1):73-4. doi: 10.1684/ejd.2008.0547.
6
Nephrogenic Systemic Fibrosis on Mammography.乳腺钼靶检查中的肾源性系统性纤维化
Curr Probl Diagn Radiol. 2015 Nov-Dec;44(6):517-20. doi: 10.1067/j.cpradiol.2015.03.001. Epub 2015 Mar 9.
7
Case report. Appearance of nephrogenic fibrosing dermopathy on a bone scan.病例报告。骨扫描显示肾源性纤维化皮肤病表现。
Br J Radiol. 2009 Feb;82(974):e35-6. doi: 10.1259/bjr/20570152.
8
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?基于钆的对比剂与肾源性系统性纤维化:它为何发生以及我们从中得到哪些教训?
J Magn Reson Imaging. 2009 Dec;30(6):1236-9. doi: 10.1002/jmri.21979.
9
Gadolinium-based contrast agents in children.儿童使用的钆基造影剂
Pediatr Radiol. 2018 Aug;48(9):1188-1196. doi: 10.1007/s00247-018-4165-1. Epub 2018 Aug 4.
10
Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.肾源性系统性纤维化:一种由钆暴露引起的全身性纤维性疾病。
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):489-503. doi: 10.1016/j.berh.2012.07.008.

引用本文的文献

1
Iodinated contrast media shortage: Insights and guidance from two major public hospitals.碘对比剂短缺:两家大型公立医院的见解和指导。
J Med Imaging Radiat Oncol. 2022 Oct;66(7):946-956. doi: 10.1111/1754-9485.13444. Epub 2022 Jun 10.
2
MR Angiography Series: Fundamentals of Non-Contrast-enhanced MR Angiography.磁共振血管造影系列:非对比增强磁共振血管造影基础。
Radiographics. 2021 Sep-Oct;41(5):E157-E158. doi: 10.1148/rg.2021210141.